We offer four human-on-a-chip systems for disease modeling and drug testing. These benchmark, multi-organ, human-based screening platforms are ideal for identifying first-in-class drugs and developing novel medicines for incompletely understood, complex diseases.
In addition, we can customize our systems by allowing customers to choose which organs to use in the model or to even build the model from organ tissues from a specific patient. These customizations make our systems especially appropriate for rare disease efficacy models.
Because each customer is as unique as the research question they’re planning to answer, our human-on-a-chip systems are configurable to your unique needs.
Our customers can select the organs for their human-on-a-chip system, including ones not present in the benchmark platforms, tailoring the design and readouts to maximize the generation of data relevant to their unique goals.